Moyamoya in sickle cell disease demonstrated by DSA and Hexabrix.
We draw attention to the value of selective digital subtraction angiography (DSA) and ioxaglate meglumine (Hexabrix) in demonstrating extensive cerebral collateral circulation (moyamoya) in a patient with homozygous sickle cell disease.
D000328:Adult; D000755:Anemia, Sickle Cell / Q000150:complications*; D001157:Arterial Occlusive Diseases / Q000000981:diagnostic imaging*; D002533:Cerebral Angiography / Q000379:methods*; D003287:Contrast Media; D005260:Female; D006801:Humans; D007463:Iodobenzoates; D007485:Ioxaglic Acid; D009072:Moyamoya Disease / Q000000981:diagnostic imaging* / Q000209:etiology; D013382:Subtraction Technique; D014283:Triiodobenzoic Acids
D003287:Contrast Media; D007463:Iodobenzoates; D014283:Triiodobenzoic Acids; D007485:Ioxaglic Acid